PL3102950T3 - Biomarker i sposoby do wczesnego diagnozowania choroby alzheimera - Google Patents
Biomarker i sposoby do wczesnego diagnozowania choroby alzheimeraInfo
- Publication number
- PL3102950T3 PL3102950T3 PL15703516T PL15703516T PL3102950T3 PL 3102950 T3 PL3102950 T3 PL 3102950T3 PL 15703516 T PL15703516 T PL 15703516T PL 15703516 T PL15703516 T PL 15703516T PL 3102950 T3 PL3102950 T3 PL 3102950T3
- Authority
- PL
- Poland
- Prior art keywords
- biomarker
- alzheimer
- disease
- methods
- early diagnosis
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 238000013399 early diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/48—Nerve growth factor [NGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/515—Angiogenesic factors; Angiogenin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/521—Chemokines
- G01N2333/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461932307P | 2014-01-28 | 2014-01-28 | |
| EP14152770.5A EP2899543A1 (en) | 2014-01-28 | 2014-01-28 | Biomarker and methods for early diagnosis of Alzheimer's disease |
| EP15703516.3A EP3102950B1 (en) | 2014-01-28 | 2015-01-28 | Biomarker and methods for early diagnosis of alzheimer's disease |
| PCT/EP2015/051677 WO2015113995A1 (en) | 2014-01-28 | 2015-01-28 | Biomarker and methods for early diagnosis of alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3102950T3 true PL3102950T3 (pl) | 2019-08-30 |
Family
ID=50000853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15703516T PL3102950T3 (pl) | 2014-01-28 | 2015-01-28 | Biomarker i sposoby do wczesnego diagnozowania choroby alzheimera |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10352949B2 (pl) |
| EP (2) | EP2899543A1 (pl) |
| JP (1) | JP6716458B2 (pl) |
| KR (1) | KR20160146650A (pl) |
| CN (1) | CN106062563B (pl) |
| AU (1) | AU2015212908B2 (pl) |
| CA (1) | CA2937169C (pl) |
| DK (1) | DK3102950T3 (pl) |
| ES (1) | ES2718378T3 (pl) |
| HU (1) | HUE043563T2 (pl) |
| IL (1) | IL246917B (pl) |
| PL (1) | PL3102950T3 (pl) |
| RU (1) | RU2687272C2 (pl) |
| SI (1) | SI3102950T1 (pl) |
| WO (1) | WO2015113995A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3032255A1 (en) * | 2016-07-28 | 2018-02-01 | Aurin Biotech Inc. | Salivary abeta42 levels as prognostic indicators for alzheimer's disease |
| CN106645755B (zh) * | 2016-12-30 | 2018-09-25 | 深圳大学 | 一种ad生物标记物及其检测方法 |
| BR112019017949A2 (pt) * | 2017-04-11 | 2020-05-19 | Nestle Sa | níveis de ácidos graxos ômega-3 e vitamina d para identificar e atenuar o envelhecimento cognitivo em indivíduos |
| CN107238711B (zh) * | 2017-05-18 | 2019-07-23 | 无锡市精神卫生中心 | 一种检测阿尔茨海默病外周血蛋白标志物的诊断试剂盒及其检测方法 |
| SG11202001833WA (en) * | 2017-08-28 | 2020-03-30 | Vitality Wellness Nz Ltd | Improvements in igf-1 analysis, adjustment and disease management of non-neurological and/or neurological conditions |
| KR102473086B1 (ko) * | 2019-03-06 | 2022-12-02 | 한양대학교 에리카산학협력단 | 은 나노갭 쉘을 이용한 알츠하이머병 진단방법 |
| CN110333310B (zh) * | 2019-08-16 | 2022-02-11 | 大连医科大学附属第一医院 | 一组用于诊断受试者中的ad或确定受试者中发生ad的风险的生物标志物及其应用 |
| KR20220104706A (ko) * | 2019-10-28 | 2022-07-26 | 에전 | 알츠하이머병의 침묵 단계를 진단하기 위한 바이오마커 및 이의 용도 |
| CN111471095B (zh) * | 2020-01-15 | 2021-12-21 | 上海众启生物科技有限公司 | 用于阿尔茨海默症自身抗体检测的含jmjd2d蛋白片段的组合物 |
| CN113125746B (zh) * | 2021-03-05 | 2022-05-24 | 华中科技大学 | 用于预测老年人发生ad的风险的生物标志物和试剂盒及其应用 |
| US11940450B2 (en) | 2021-03-16 | 2024-03-26 | University Of Connecticut | Biomarker panel for non-invasive diagnosis of congenital renal dysfunction |
| CN112858697B (zh) * | 2021-03-29 | 2024-03-01 | 鲁东大学 | ALG-2-interacting protein X在制备分子标志物中的应用 |
| CN117451995A (zh) * | 2021-12-06 | 2024-01-26 | 上海市精神卫生中心（上海市心理咨询培训中心） | 用于预测应激后精神心理症状发生的免疫检测试剂盒及应用 |
| KR20230142182A (ko) * | 2022-04-01 | 2023-10-11 | 한양대학교 산학협력단 | 뇌척수액과 혈액 내 바이오마커들을 활용한 알츠하이머병 진단 시스템 |
| CN116990395A (zh) * | 2022-04-26 | 2023-11-03 | 中国科学院深圳先进技术研究院 | 一种基于粪便的阿尔兹海默症生物标志物及其应用 |
| WO2024015951A2 (en) * | 2022-07-15 | 2024-01-18 | Seq Biomarque, Llc | Methods and materials for identifying biomarkers and/or pathways associated with alzheimer's disease |
| CN116063447B (zh) * | 2022-09-13 | 2023-11-03 | 北京湃德智健科技有限公司 | 用于检测adap自身抗体的抗原多肽及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005005292A1 (ja) | 2003-07-09 | 2005-01-20 | Bridgestone Corporation | コンベアベルトの伸び測定方法および伸び測定装置、コンベアベルトの摩耗度合測定方法およびコンベアベルト摩耗度合測定装置、コンベアベルトの温度測定方法およびコンベアベルト温度測定装置、ならびに、ゴム磁石シートおよびゴム磁石シートの製造方法 |
| WO2005017203A2 (en) * | 2003-07-11 | 2005-02-24 | Yale University | Systems and methods for diagnosing and treating psychological and behavioral conditions |
| GB0326685D0 (en) | 2003-11-15 | 2003-12-17 | Trojan Hardware & Designs Ltd | Double-axis adjustable hinge |
| US20060094064A1 (en) | 2003-11-19 | 2006-05-04 | Sandip Ray | Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| JP2007513337A (ja) * | 2003-11-19 | 2007-05-24 | サトリス， インコーポレイテッド | アルツハイマー病の診断方法、層化方法およびモニタリング方法 |
| CN1977049A (zh) * | 2004-04-26 | 2007-06-06 | 儿童医疗中心有限公司 | 用于检测疾病的血小板生物标志物 |
| AU2005290314A1 (en) * | 2004-09-28 | 2006-04-06 | Singulex, Inc. | System and method for spectroscopic analysis of single particles |
| KR101439828B1 (ko) * | 2005-11-30 | 2014-09-17 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
| NZ589436A (en) | 2008-06-03 | 2012-12-21 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| MX2011007030A (es) * | 2008-12-30 | 2011-07-20 | Centocor Ortho Biotech Inc | Marcadores sericos que predicen la respuesta clinica a los anticuerpos anti-factor de necrosis tumoral alfa en pacientes con espondilitis anquilosante. |
| EP2483694A1 (en) * | 2009-10-01 | 2012-08-08 | Protagen AG | Biomarkers for alzheimer's disease |
| JP2013511732A (ja) * | 2009-11-24 | 2013-04-04 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション | 神経障害の診断、診断補助および／またはその進行のモニタリングのための方法、キットおよび試薬 |
| US20130040844A1 (en) * | 2010-01-28 | 2013-02-14 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarkers of aging for detection and treatment of disorders |
| WO2011143574A2 (en) * | 2010-05-14 | 2011-11-17 | The Trustees Of The University Of Pennsylvania | Plasma biomarkers for diagnosis of alzheimer's disease |
| AU2012249288C1 (en) * | 2011-04-29 | 2017-12-21 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
-
2014
- 2014-01-28 EP EP14152770.5A patent/EP2899543A1/en not_active Withdrawn
-
2015
- 2015-01-28 EP EP15703516.3A patent/EP3102950B1/en active Active
- 2015-01-28 CA CA2937169A patent/CA2937169C/en active Active
- 2015-01-28 DK DK15703516.3T patent/DK3102950T3/en active
- 2015-01-28 CN CN201580006178.XA patent/CN106062563B/zh active Active
- 2015-01-28 SI SI201530673T patent/SI3102950T1/sl unknown
- 2015-01-28 KR KR1020167020678A patent/KR20160146650A/ko not_active Application Discontinuation
- 2015-01-28 PL PL15703516T patent/PL3102950T3/pl unknown
- 2015-01-28 WO PCT/EP2015/051677 patent/WO2015113995A1/en active Application Filing
- 2015-01-28 AU AU2015212908A patent/AU2015212908B2/en active Active
- 2015-01-28 ES ES15703516T patent/ES2718378T3/es active Active
- 2015-01-28 JP JP2016549268A patent/JP6716458B2/ja active Active
- 2015-01-28 HU HUE15703516A patent/HUE043563T2/hu unknown
- 2015-01-28 RU RU2016134839A patent/RU2687272C2/ru active
-
2016
- 2016-07-24 IL IL246917A patent/IL246917B/en active IP Right Grant
- 2016-07-27 US US15/221,069 patent/US10352949B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2718378T3 (es) | 2019-07-01 |
| AU2015212908B2 (en) | 2021-05-06 |
| KR20160146650A (ko) | 2016-12-21 |
| HUE043563T2 (hu) | 2019-09-30 |
| EP3102950A1 (en) | 2016-12-14 |
| RU2687272C2 (ru) | 2019-05-13 |
| DK3102950T3 (en) | 2019-04-01 |
| WO2015113995A1 (en) | 2015-08-06 |
| EP3102950B1 (en) | 2018-12-26 |
| CA2937169C (en) | 2022-08-23 |
| CA2937169A1 (en) | 2015-08-06 |
| RU2016134839A (ru) | 2018-03-12 |
| AU2015212908A1 (en) | 2016-08-04 |
| CN106062563B (zh) | 2020-07-28 |
| EP2899543A1 (en) | 2015-07-29 |
| IL246917A0 (en) | 2016-09-29 |
| SI3102950T1 (sl) | 2019-05-31 |
| US20160334422A1 (en) | 2016-11-17 |
| JP2017504808A (ja) | 2017-02-09 |
| JP6716458B2 (ja) | 2020-07-01 |
| CN106062563A (zh) | 2016-10-26 |
| IL246917B (en) | 2019-06-30 |
| US10352949B2 (en) | 2019-07-16 |
| RU2016134839A3 (pl) | 2018-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL246917B (en) | Biomarker and early diagnosis methods for Alzheimer's disease | |
| IL260678B (en) | Systems and methods to improve diagnosis of diseases | |
| IL285722A (en) | Methods for treating Alzheimer's disease | |
| PL3171765T3 (pl) | Zbieranie i analiza danych do celów diagnostycznych | |
| IL256685B (en) | An isolated tau-binding antibody and its use in the treatment and diagnosis of tauopathy | |
| IL247085B (en) | Methods for treating Alzheimer's disease | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| IL276516A (en) | Methods for diagnosing and treating inflammatory bowel disease | |
| ES2972858T3 (es) | Método para diagnóstico, tratamiento y prevención de la enfermedad de Parkinson | |
| GB201504432D0 (en) | Materials and methods for diagnosis and treatment of alzheimers disease | |
| GB201303936D0 (en) | Methods and Compositions for the Diagnosis of Alzheimers Disease | |
| HUE055913T2 (hu) | Módszerek és készítmények a glioblastoma diagnosztizálására és kezelésére | |
| EP3232198A4 (en) | Biomarker for diagnosis of hepatoma and use thereof | |
| GB201413357D0 (en) | Antibodies for treatment and diagnosis | |
| LT3171174T (lt) | Laktoferinas, skirtas naudoti alzheimerio ligos diagnozei arba prognozei | |
| EP3137907A4 (en) | Methods and compositions for the diagnosis and treatment of kawasaki disease | |
| HUE049438T2 (hu) | Eljárás neurodegeneratív betegségek diagnosztizálására | |
| HK1255691A1 (zh) | 對疾病進行組織學診斷和治療的方法 | |
| IL248935A0 (en) | Diagnostic testing and treatment/prevention of Alzheimer's disease | |
| HK1250261A1 (zh) | 診斷阿爾茨海默症的方法 | |
| PL3449009T3 (pl) | Biomarkery mikroRNA we krwi do diagnozowania choroby Alzheimera | |
| GB201410118D0 (en) | Early diagnosis of leptospire | |
| EP3132438A4 (en) | Training methods for improved assaying of clinical symptoms in clinical trial subjects | |
| GB201621945D0 (en) | Method of diagnosis | |
| GB201417670D0 (en) | Markers and methods for predicting prodromal stages of alzheimer's disease |